Cardiac Arrest within the First 24 Hours after Hospital Admission in ST-segment Elevation Acute Coronary Syndromes. The ARGEN-IAM-ST Registry

Costa, Yanina Castillo; Rafaelli, Alessis; Mauro, Víctor M.; Charask, Adrián; Tajer, Carlos; Gagliardi, Juan

doi:10.7775/rac.v87.i3.13564

Cited by 5 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…O IAM destaca-se como uma das etiologias da PCR por induzir arritmias ventriculares, como a FV, a qual, apesar de não ser o ritmo cardíaco mais comum, é responsável por mais de 60% dos casos de parada cardíaca súbita com posterior morte súbita (MEDINA et al, 2020;TAKAHASHI et al, 2018). A presença do supradesnivelamento do segmento ST constitui ainda um fator de risco para a PCR nas primeiras horas após a admissão ao serviço, com prevalência de associação desses eventos de 7% a 10% (COSTA et al, 2019).…”

Section: Desenvolvimentounclassified

Terapia de reperfusão após reversão de parada cardiorrespiratória por infarto do miocárdio: relato de caso

Rodrigues¹,

Ferreira²,

Pereira³

et al. 2022

Revista Científica Multidisciplinar Núcleo do Conhecimento

View full text Add to dashboard Cite

O artigo traz um relato de caso sobre a aplicação da terapia de reperfusão após reversão de uma parada cardiorrespiratória com fibrilação ventricular após um infarto agudo do miocárdio com supradesnivelamento do segmento ST, com posterior discussão das principais indicações e manejo adequado das estratégias de reperfusão miocárdica. O objetivo deste estudo é demonstrar, a partir de um relato de caso, como as corretas indicações de reperfusão podem mudar positivamente o prognóstico de um Infarto Agudo do Miocárdio com Supradesnivelamento do Segmento ST (IAMCST), sendo a pergunta norteadora: Qual é a relação prognóstica entre a evolução favorável de um caso de IAMCST e corretas indicações de terapia de reperfusão? A metodologia usada foi a revisão do prontuário de paciente e a revisão bibliográfica de artigos publicados no PubMed e Scielo, bem como a V Diretriz da Sociedade Brasileira de Cardiologia. O resultado foi a reperfusão eletrocardiográfica em 90 minutos após terapia trombolítica seguida de cateterismo cardíaco e angioplastia, com alta da paciente sem sequelas após uma semana.

show abstract

Section: Desenvolvimentounclassified

Terapia de reperfusão após reversão de parada cardiorrespiratória por infarto do miocárdio: relato de caso

Rodrigues¹,

Ferreira²,

Pereira³

et al. 2022

Revista Científica Multidisciplinar Núcleo do Conhecimento

View full text Add to dashboard Cite

show abstract

Heart Disease and Stroke Statistics—2021 Update

Virani¹,

Alonso²,

Aparicio³

et al. 2021

Circulation

4,055

1,396

View full text Add to dashboard Cite

BACKGROUND: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). METHODS: The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update. The 2021 Statistical Update is the product of a full year’s worth of effort by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year’s edition includes data on the monitoring and benefits of cardiovascular health in the population, an enhanced focus on social determinants of health, adverse pregnancy outcomes, vascular contributions to brain health, the global burden of cardiovascular disease, and further evidence-based approaches to changing behaviors related to cardiovascular disease. RESULTS: Each of the 27 chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. CONCLUSIONS: The Statistical Update represents a critical resource for the lay public, policy makers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

show abstract

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

Tsao¹,

Aday²,

Almarzooq³

et al. 2022

Circulation

3,527

2,336

View full text Add to dashboard Cite

Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). Methods: The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update. The 2022 Statistical Update is the product of a full year’s worth of effort by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year’s edition includes data on the monitoring and benefits of cardiovascular health in the population and an enhanced focus on social determinants of health, adverse pregnancy outcomes, vascular contributions to brain health, and the global burden of cardiovascular disease and healthy life expectancy. Results: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. Conclusions: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

show abstract

Cardiac Arrest within the First 24 Hours after Hospital Admission in ST-segment Elevation Acute Coronary Syndromes. The ARGEN-IAM-ST Registry

Cited by 5 publications

References 0 publications

Terapia de reperfusão após reversão de parada cardiorrespiratória por infarto do miocárdio: relato de caso

Terapia de reperfusão após reversão de parada cardiorrespiratória por infarto do miocárdio: relato de caso

Heart Disease and Stroke Statistics—2021 Update

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

Contact Info

Product

Resources

About